Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pleural Effusion, Malignant 1Osteoporosis 1Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

talimogene laherparepvec 1rilotumumab 1lipoplatin 1ganitumab 1cediranib 1Zoledronic Acid 1Verteporfin 1Thoracentesis 1Therapeutics 1Talc 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Spectrum Analysis 1Sodium Chloride 1SPI-77, liposomal 1Radiotherapy, Conformal 1Photochemotherapy 1Nivolumab 1Naproxen 1Immunohistochemistry 1Fluorodeoxyglucose F18 1Fentanyl 1Etoposide 1Drug Therapy 1Doxycycline 1Dihematoporphyrin Ether 1Darbepoetin alfa 1Coal Tar 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Pleural Effusion, Malignant × Spectrum Analysis × Clear all
NCT00601848 2020-11-24

Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura

Abramson Cancer Center at Penn Medicine

Phase 2 Terminated
9 enrolled 5 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡